Key structure of brij for overcoming multidrug resistance in cancer

Biomacromolecules

Volumn 14, Issue 2, 2013, Pages 424-430

  Tang, Jingling ^b   Wang, Yongjun ^c   Wang, Dun ^c   Wang, Yuhua ^a   Xu, Zhenghong ^a   Racette, Kelly ^a   Liu, Feng ^a  

^a University of North Carolina   (United States)

^b HARBIN MEDICAL UNIVERSITY   (China)

^c SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AFTER-TREATMENT; ATP DEPLETION; ATP-ASE ACTIVITY; BRIJ SURFACTANT; CELL LINES; CELL VIABILITY; CHEMOTHERAPY TREATMENT; ETHYLENE OXIDES; HYDROPHILIC LIPOPHILIC BALANCE; HYDROPHOBIC TAILS; INTRACELLULAR ACCUMULATION; INTRACELLULAR ATP; KEY STRUCTURES; MULTIDRUG RESISTANCE; MULTIDRUG RESISTANTS; NANOCRYSTAL (NCS); PACLITAXEL; POSITIVE CORRELATIONS; POTENTIAL MECHANISM; REPEATING UNIT; TUMOR CELLS; WESTERN BLOTTING;

CELL CULTURE; CHEMOTHERAPY; DISEASES; HYDROPHILICITY; NONIONIC SURFACTANTS;

CELLS;

ADENOSINE TRIPHOSPHATASE; BRIJ 97; CARBON; CETOMACROGOL; ETHYLENE OXIDE; NANOCRYSTAL; PACLITAXEL; POLIDOCANOL; POLYOXYETHYLENE STEARYL ETHER; UNCLASSIFIED DRUG; VERAPAMIL;

ARTICLE; CANCER CELL; CANCER GROWTH; CANCER RESISTANCE; CELL VIABILITY; CHEMICAL STRUCTURE; CONTROLLED STUDY; CYTOTOXICITY; DRUG FORMULATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HYDROPHILICITY; HYDROPHOBICITY; IN VITRO STUDY; LIPOPHILICITY; MOLECULAR WEIGHT; MULTIDRUG RESISTANCE; PARTICLE SIZE; PRIORITY JOURNAL; WESTERN BLOTTING;

ADENOSINE TRIPHOSPHATASES; ADENOSINE TRIPHOSPHATE; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BIOLOGICAL TRANSPORT; CALCIUM CHANNEL BLOCKERS; CELL LINE, TUMOR; CELL SURVIVAL; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; LUNG NEOPLASMS; NANOPARTICLES; P-GLYCOPROTEIN; PACLITAXEL; PLANT OILS; POLYETHYLENE GLYCOLS; SURFACE-ACTIVE AGENTS; VERAPAMIL;

EID: 84873657088     PISSN: 15257797     EISSN: 15264602     Source Type: Journal    
DOI: 10.1021/bm301661w     Document Type: Article

References (30)

1. Gottesman, M. M.; Fojo, T.; Bates, S. E. Nat. Rev. Cancer 2002, 2, 48-58
2. Shapira, A.; Livney, Y. D.; Broxterman, H. J.; Assaraf, Y. G. Drug Resist. Updates 2011, 14, 150-163
3. Krupka, T. M.; Weinberg, B. D.; Wu, H.; Ziats, N. P.; Exner, A. A. Exp. Biol. Med. 2007, 232, 950-957
4. Kabanov, A. V.; Batrakova, E. V.; Alakhov, V. Y. J. Controlled Release 2003, 91, 75-83
5. Batrakova, E. V.; Li, S.; Vinogradov, S. V.; Alakhov, V. Y.; Miller, D. W.; Kabanov, A. V. J. Pharmacol. Exp. Ther. 2001, 299, 483-493
6. Batrakova, E. V.; Li, S.; Li, Y.; Alakhov, V. Y.; Kabanov, A. V. Pharm. Res. 2004, 21, 2226-2233
7. Batrakova, E. V.; Li, S.; Alakhov, V. Y.; Miller, D. W.; Kabanov, A. V. J. Pharmacol. Exp. Ther. 2003, 304, 845-854
8. Batrakova, E. V.; Li, S.; Alakhov, V. Y.; Elmquist, W. F.; Miller, D. W.; Kabanov, A. V. Pharm. Res. 2003, 20, 1581-1590
9. Batrakova, E. V.; Li, S.; Brynskikh, A. M.; Sharma, A. K.; Li, Y.; Boska, M.; Gong, N.; Mosley, R. L.; Alakhov, V. Y.; Gendelman, H. E.; Kabanov, A. V. J. Controlled Release 2010, 143, 290-301
10. Collnot, E. M.; Baldes, C.; Schaefer, U. F.; Edgar, K. J.; Wempe, M. F.; Lehr, C. M. Mol. Pharmaceutics 2010, 7, 642-651
11. Collnot, E. M.; Baldes, C.; Wempe, M. F.; Kappl, R.; Huttermann, J.; Hyatt, J. A.; Edgar, K. J.; Schaefer, U. F.; Lehr, C. M. Mol. Pharmaceutics 2007, 4, 465-474
12. Collnot, E. M.; Baldes, C.; Wempe, M. F.; Hyatt, J.; Navarro, L.; Edgar, K. J.; Schaefer, U. F.; Lehr, C. M. J. Controlled Release 2006, 111, 35-40
13. Liu, Y.; Huang, L.; Liu, F. Mol. Pharmaceutics 2010, 7, 863-869
14. Lo, Y. L. J. Controlled Release 2003, 90, 37-48
15. Yu, H.; Hu, Y. Q.; Ip, F. C.; Zuo, Z.; Han, Y. F.; Ip, N. Y. Biopharm. Drug Dispos. 2011, 32, 140-150
16. Dong, X.; Mattingly, C. A.; Tseng, M. T.; Cho, M. J.; Liu, Y.; Adams, V. R.; Mumper, R. J. Cancer Res. 2009, 69, 3918-3926
17. Deng, J.; Huang, L.; Liu, F. Int. J. Pharm. 2010, 390, 242-249
18. Pasquali, R. C.; Taurozzi, M. P.; Bregni, C. Int. J. Pharm. 2008, 356, 44-51
19. Tagami, T.; Ernsting, M. J.; Li, S. D. J. Controlled Release 2011, 154, 290-297
20. Zhang, P.; Ling, G.; Sun, J.; Zhang, T.; Yuan, Y.; Sun, Y.; Wang, Z.; He, Z. Biomaterials 2011, 32, 5524-5533
21. Chavanpatil, M. D.; Patil, Y.; Panyam, J. Int. J. Pharm. 2006, 320, 150-156
22. Onyuksel, H.; Jeon, E.; Rubinstein, I. Cancer Lett. 2009, 274, 327-330
23. Yim, H.; Na, K. Biomacromolecules 2010, 11, 2387-2393
24. Ren, F.; Chen, R.; Wang, Y.; Sun, Y.; Jiang, Y.; Li, G. Pharm. Res. 2011, 28, 897-906
25. Nobili, S.; Landini, I.; Mazzei, T.; Mini, E. Med. Res. Rev. 2011, 32, 1220-1262
26. Chen, C. H.; Cuong, N. V.; Chen, Y. T.; So, R. C.; Liau, I.; Hsieh, M. F. J. Nanosci. Nanotechnol. 2011, 11, 53-60
27. Perez-Tomas, R. Curr. Med. Chem. 2006, 13, 1859-1876
28. Batrakova, E. V.; Li, S.; Elmquist, W. F.; Miller, D. W.; Alakhov, V. Y.; Kabanov, A. V. Br. J. Cancer 2001, 85, 1987-1997
29. Yamagata, T.; Kusuhara, H.; Morishita, M.; Takayama, K.; Benameur, H.; Sugiyama, Y. J. Controlled Release 2007, 124, 1-5
30. Li, P. Y.; Lai, P. S.; Hung, W. C.; Syu, W. J. Biomacromolecules 2010, 11, 2576-2782